LAX.SH
CAMLIN FINE SCIENCES LTD·CHEMICALS 65.05·Chemicals & Petrochemicals Companies
Price
109.45
+0.98%52W Range
Market Cap
₹2,102.50 Cr
Traded: ₹5.71 Cr (0.27%) 0.0x
Free Float: ₹835.95 Cr (0.68% of FF traded)
Volume · 60D trend
5.23 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -1.0% | -2.0% | -7.0% | -- | -- | Decelerating |
| Sales | +12.0% | +10.0% | +6.0% | -- | +11.0% | Stable |
| Profit | -- | -- | -- | -- | -94.0% | -- |
| Return | +4.0% | -1.0% | -2.0% | -21.0% | -- | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 520 | 425 | 441 | 460 | 408 | 432 | 431 | 417 | 381 | 377 | 386 | 406 | 420 | 427 | 388 | 483 |
| Expenses | 511 | 404 | 420 | 427 | 387 | 370 | 375 | 366 | 352 | 345 | 363 | 381 | 381 | 383 | 338 | 428 |
| Operating Profit | 9 | 21 | 21 | 33 | 20 | 62 | 56 | 52 | 29 | 31 | 23 | 25 | 39 | 44 | 50 | 55 |
| OPM % | 1.8% | 5.0% | 4.7% | 7.0% | 5.0% | 14.0% | 13.0% | 12.0% | 8.0% | 8.0% | 6.0% | 6.0% | 9.0% | 10.0% | 13.0% | 11.0% |
| Other Income | -10 | 103 | -24 | -4 | 0 | -22 | -8 | -151 | -15 | -96 | 2 | 2 | 6 | -8 | 10 | 3 |
| Interest | 14 | 23 | 17 | 19 | 15 | 15 | 34 | 26 | 23 | 16 | 14 | 20 | 10 | 10 | 12 | 18 |
| Depreciation | 19 | 21 | 16 | 19 | 16 | 17 | 14 | 17 | 15 | 13 | 21 | 19 | 19 | 18 | 16 | 14 |
| Profit Before Tax | -34 | 80 | -37 | -9 | -11 | 8 | 0 | -142 | -23 | -94 | -10 | -12 | 16 | 8 | 32 | 26 |
| Tax % | -1.0% | -8.0% | 0.0% | 65.0% | 0.0% | 98.0% | 2164.0% | -18.0% | 48.0% | -13.0% | 47.0% | 72.0% | 25.0% | 59.0% | 28.0% | 61.0% |
| Net Profit | -34 | 86 | -37 | -15 | -11 | 0 | -7 | -116 | -35 | -82 | -14 | -21 | 12 | 3 | 23 | 10 |
| Exceptional Items | -13 | 77 | -27 | -9 | -8 | -35 | -9 | -163 | -16 | -101 | 0 | 0 | 0 | -10 | 0 | 0 |
| EPS (Rs) | -1.6 | 4.6 | -1.9 | -0.8 | -0.5 | -0.0 | -0.2 | -5.3 | -1.8 | -4.1 | -0.6 | -1.0 | 0.8 | 0.5 | 1.4 | 0.7 |
| Sales Growth (YoY) | 27.5% | -1.6% | 2.2% | 10.2% | 7.1% | 14.6% | 11.7% | 2.8% | -9.2% | -11.7% | -0.5% | -16.0% | 9.3% | 9.6% | 1.8% | -- |
| Sales Growth (QoQ) | -- | -- | -0.7% | 8.5% | -3.0% | 1.4% | 3.4% | 9.4% | 1.1% | -2.3% | -4.9% | -3.3% | -1.6% | 10.1% | -19.7% | -- |
| OP Growth (YoY) | -55.0% | -66.1% | -62.5% | -36.5% | -31.0% | 100.0% | 143.5% | 108.0% | -25.6% | -29.5% | -54.0% | -54.5% | -- | -- | -- | -- |
| OP Growth (QoQ) | -57.1% | 0.0% | -36.4% | 65.0% | -67.7% | 10.7% | 7.7% | 79.3% | -6.5% | 34.8% | -8.0% | -35.9% | -11.4% | -12.0% | -9.1% | -- |
| Profit Growth (YoY) | -607.0% | -60.0% | -1563.0% | -116.0% | 84.0% | 76.0% | 107.0% | 289.0% | -215.0% | 32.0% | -149.0% | -249.0% | 164.0% | -8.0% | -16.0% | 335.0% |
| EPS Growth (YoY) | -- | -- | -759.1% | 85.7% | 70.7% | 99.0% | 65.1% | -417.5% | -318.1% | -890.4% | -146.3% | -239.2% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -- | -148.7% | -43.4% | -1225.0% | 81.8% | 95.9% | -194.5% | 56.0% | -552.4% | 38.8% | -224.1% | 59.6% | -61.8% | 83.8% | -- |
| OP Margin | -- | -- | 4.8% | 7.2% | 4.5% | 13.5% | 13.0% | 12.5% | 7.6% | 8.2% | 6.0% | 6.2% | 9.3% | 10.3% | 12.9% | 11.4% |
| Net Margin | -- | -- | -8.1% | -3.3% | -2.6% | 0.0% | -1.6% | -27.8% | -9.2% | -21.8% | -3.6% | -5.2% | 2.9% | 0.7% | 5.9% | 2.1% |
| Material Cost % | 59.0% | 52.0% | 54.0% | 54.0% | 55.0% | 49.0% | 50.0% | 52.0% | 54.0% | 55.0% | 55.0% | 55.0% | 51.0% | 49.0% | 48.0% | 49.0% |
| Employee Cost % | 14.0% | 16.0% | 14.0% | 13.0% | 14.0% | 11.0% | 11.0% | 12.0% | 12.0% | 11.0% | 12.0% | 11.0% | 10.0% | 10.0% | 11.0% | 8.0% |
| P/S | 1.14 | 1.36 | 1.31 | 1.62 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 377.41 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 2.02 | 2.32 | 2.62 | 3.19 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Transcript of the Earnings Call Q1FY27
Newspaper Publication - Unaudited Financial Results for the quarter ended June 30, 2026.
Scrutinizers Report with Voting Results of 33rd AGM
Proceedings of the 33rd AGM
Un-audited Financial Results for the quarter ended June 30, 2026
Outcome of Board Meeting dated August 11, 2026
Investor Presentation Q1 FY27
Investor Call Recording Q1 FY27
Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 28, 2026 for Ashish Subhash Dandekar
Newspaper Publication - Dispatch of Notice of 33rd Annual General Meeting of the Company.
BRSR for the FY 2025-26.
Annual Report for the FY 2025-26.
Enclosed.
Enclosed.
Newspaper Publication pursuant to 33rd Annual General Meeting of the Company.
Enclosed
Certificate under Re. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.
Resignation of Senior Management Personnel of the Company.
Enclosed.
Intimation of Schedule of Investor meet
Closure of Trading Window
Enclosed.
Transcript of the Investor Call dated May 26, 2026
Annual Secretarial Compliance Report for the year ended March 31, 2026.
Newspaper Publication - Audited Financial Results for the quarter and year ended 31.03.2026
Outcome of Board Meeting
Change in Management
Investor Presentation - Q4 & FY26
Audited Financial Results as on March 31, 2026
Investor Call Recording Q4 & FY26
Disclosure regarding fire incident occurred at the Diphenol Plant of the Company.
Closure of operations of Diphenol Plant of the Company.
Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve the Audited Standalone ....
Intimation of Schedule of Investor Meet
Monitoring Agency Report for the quarter ended March 31, 2026, for Rights Issue.
Outcome of Postal Ballot
Postal Ballot - Scrutinizers Report with Voting Results
Enclosed.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 21, 2026 for Ashish Dandekar
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 13, 2026 for Ashish Subhash Dandekar
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on April ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 09, 2026 for Ashish Subhash Dandekar
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on April ....
Enclosed.
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.
Newspaper Publication - Notice of Postal Ballot
Notice of Postal Ballot
Enclosed.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March ....
Annual Reports
15Credit Ratings
6Concalls
42Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Sep 2023
30 Sept 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Feb 2022
28 Feb 2022Jan 2022
31 Jan 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021May 2021
31 May 2021May 2021
31 May 2021Feb 2021
28 Feb 2021Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Dec 2019
31 Dec 2019Dec 2019
31 Dec 2019Nov 2019
30 Nov 2019Aug 2019
31 Aug 2019Aug 2019
31 Aug 2019May 2019
31 May 2019Feb 2019
28 Feb 2019Feb 2019
28 Feb 2019Nov 2018
30 Nov 2018Nov 2018
30 Nov 2018May 2016
31 May 2016Held by Mutual Funds
5 schemes hold CAMLINFINE · sorted by weight